Endoxifen for mammographic density reduction-results from the KARISMA endoxifen trial

Karolinska Mammography Project
for Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

Karolinska Mammography Project
for Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

2026

Endoxifen for mammographic density reduction-results from the KARISMA endoxifen trial

Per Hall, Mattias Hammarström, Jenny Bergqvist, Kamila Czene, Mikael Eriksson, Marike Gabrielson, José Tapia, Steven Quay, Stephen Nash, Magnus Bäcklund

https://pubmed.ncbi.nlm.nih.gov/42070780/

Karolinska Mammography Project for Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

Karolinska Mammography Projectfor Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

2026

Endoxifen for mammographic density reduction-results from the KARISMA endoxifen trial

Karolinska Mammography Project
for Risk Prediction of Breast Cancer

Karolinska Mammography Project
for Risk Prediction of Breast Cancer